These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 26861928)

  • 1. Non-invasive insight into the release mechanisms of a poorly soluble drug from amorphous solid dispersions by confocal Raman microscopy.
    Punčochová K; Vukosavljevic B; Hanuš J; Beránek J; Windbergs M; Štěpánek F
    Eur J Pharm Biopharm; 2016 Apr; 101():119-25. PubMed ID: 26861928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Combined Use of Imaging Approaches to Assess Drug Release from Multicomponent Solid Dispersions.
    Punčochová K; Ewing AV; Gajdošová M; Pekárek T; Beránek J; Kazarian SG; Štěpánek F
    Pharm Res; 2017 May; 34(5):990-1001. PubMed ID: 27573574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
    Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
    Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®.
    Liu J; Zou M; Piao H; Liu Y; Tang B; Gao Y; Ma N; Cheng G
    Molecules; 2015 Jun; 20(6):11345-56. PubMed ID: 26102068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
    Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
    Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
    Chen H; Pui Y; Liu C; Chen Z; Su CC; Hageman M; Hussain M; Haskell R; Stefanski K; Foster K; Gudmundsson O; Qian F
    J Pharm Sci; 2018 Jan; 107(1):317-326. PubMed ID: 29107047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
    Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
    Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R; Sieger P; Karmwar P
    Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
    Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW
    Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.
    Zhang J; Shi Q; Tao J; Peng Y; Cai T
    Mol Pharm; 2019 Mar; 16(3):1385-1396. PubMed ID: 30716277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
    Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD; Lee PI
    J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.